Gracell Biotechnologies Correlations
A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Gracell Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Gracell Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Gracell |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Gracell Stock performing well and Gracell Biotechnologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Gracell Biotechnologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| THRX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| GLUE | 3.54 | (0.27) | 0.00 | (0.27) | 0.00 | 7.34 | 30.08 | |||
| DSGN | 4.10 | (0.19) | 0.00 | (0.23) | 0.00 | 8.72 | 24.91 | |||
| ERAS | 3.23 | (0.72) | 0.00 | (0.57) | 0.00 | 7.57 | 21.39 | |||
| NXTC | 3.55 | (0.60) | 0.00 | (0.35) | 0.00 | 6.74 | 21.57 | |||
| CTMX | 3.54 | (0.65) | 0.00 | (0.35) | 0.00 | 7.32 | 17.13 | |||
| NLTX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| SPRO | 2.59 | (0.32) | 0.00 | (0.74) | 0.00 | 5.13 | 21.98 | |||
| ASMB | 3.04 | (0.39) | 0.00 | (0.36) | 0.00 | 6.63 | 24.82 | |||
| TERN | 3.07 | (0.93) | 0.00 | (0.94) | 0.00 | 5.03 | 19.13 |
View Gracell Biotechnologies Related Equities
| Risk & Return | Correlation |
Gracell Biotechnologies Corporate Management
| Yili MBA | Chief Officer | Profile | |
| Yajin MD | Chief Officer | Profile | |
| Wei Cao | Chairman Founder | Profile | |
| Samuel MBA | Chief Officer | Profile | |
| Wendy MD | Chief Officer | Profile | |
| Erin Li | Executive Officer | Profile |
Still Interested in Gracell Biotechnologies?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.